|
|
|
|
|
|
DARU Journal of Pharmaceutical Sciences
|
|
|
|
2010;18(2) : 97-102
|
| |
| Original Article |
| Development and validation of a rapid HPLC- fluorescence method for simultaneous determination of venlafaxine and its major metabolites in human plasma |
1Ardakani Y. H., 2Foroumadi A., *1Rouini M.R.
1Biopharmaceutics and Pharmacokinetics Division, Department of Pharmaceutics, Faculty of Pharmacy, 2Drug Design & Development Research Center, Tehran University of Medical Sciences, Tehran, Iran.
|
|
Corresponding Author: |
|
|
Rouini M.R
|
|
| Received: | September 9,2009 |
| Accepted: | February 15,2010 |
| Available online: | June 19,2010 |
|
| Abstract: |
|
Background and the purpose of the study:To develop a simple, rapid and accurate HPLC method for the measurement of the venlafaxine and its main metabolites, O-desmethylvenlafaxine and O,N-didesmethylvenlafaxine in pharmacokinetic studies and therapeutic drug monitoring.Method: Chromatographic separation was achieved with a ChromolithTM Performance RP-18e 100 mm×4.6 mm column equipped with a Fluorescence detectore (λex 200 nm/λem 300 nm) The mobile phase of methanol:water (35:65, v/v) adjusted to pH 2.5 by phosphoric acid was passed through the column in an isocratic mode at flow rate of 2 ml/min. The sample preparation involved a simple, one-step, extraction with ethyl acetate.
Results:The calibration curves were linear in the concentration range of 1-300 ng/ml for all analytes (r2 > 0.998). The lower limit of quantification was 1 ng/ml for all analytes. Within and between day precisions in the measurement of quality control (QC) of samples were in the range of 1.8-14.1% for all analytes.
Conclusion:The developed procedure was used to assess the pharmacokinetics of venlafaxine and its main metabolites following oral administration of 75 mg venlafaxine to a healthy subject.
|
|
|
| Permanent Link:
http://journals.tums.ac.ir/abs/15739 |
|
|
|
|
430 KB
|
|
|
|
|
|
|
|
|
|
|
 |
|